Envestnet Asset Management Inc 10x Genomics, Inc. Transaction History

Envestnet Asset Management Inc

  • $326 Billion
  • Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 94,872 shares of TXG stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,872
Previous 95,701 0.87%
Holding current value
$1.17 Million
Previous $835,000 31.5%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$7.14 - $11.73 $5,919 - $9,724
-829 Reduced 0.87%
94,872 $1.1 Million
Q1 2025

Apr 29, 2025
BUY
$8.73 - $16.31 $105,947 - $197,938
12,136 Added 14.52%
95,701 $835,000
Q4 2024

Feb 12, 2025
SELL
$13.18 - $21.31 $292,451 - $472,847
-22,189 Reduced 20.98%
83,565 $1.2 Million
Q3 2024

Nov 06, 2024
BUY
$15.71 - $23.49 $771,533 - $1.15 Million
49,111 Added 86.7%
105,754 $2.39 Million
Q2 2024

Aug 08, 2024
BUY
$19.45 - $37.37 $261,583 - $502,589
13,449 Added 31.14%
56,643 $1.1 Million
Q1 2024

May 13, 2024
BUY
$36.08 - $54.3 $761,251 - $1.15 Million
21,099 Added 95.49%
43,194 $1.62 Million
Q4 2023

Feb 13, 2024
BUY
$34.32 - $57.55 $320,377 - $537,229
9,335 Added 73.16%
22,095 $1.24 Million
Q3 2023

Nov 13, 2023
BUY
$40.86 - $62.98 $239,439 - $369,062
5,860 Added 84.93%
12,760 $526,000
Q2 2023

Aug 04, 2023
SELL
$50.96 - $58.72 $8,000 - $9,219
-157 Reduced 2.22%
6,900 $385,000
Q1 2023

May 11, 2023
SELL
$35.33 - $55.79 $198,907 - $314,097
-5,630 Reduced 44.38%
7,057 $393,000
Q4 2022

Feb 07, 2023
SELL
$24.4 - $41.3 $14,200 - $24,036
-582 Reduced 4.39%
12,687 $462,000
Q3 2022

Nov 10, 2022
SELL
$28.48 - $52.59 $70,089 - $129,423
-2,461 Reduced 15.65%
13,269 $378,000
Q2 2022

Aug 03, 2022
BUY
$36.95 - $82.41 $68,948 - $153,777
1,866 Added 13.46%
15,730 $712,000
Q1 2022

May 04, 2022
SELL
$55.7 - $145.79 $70,571 - $184,715
-1,267 Reduced 8.37%
13,864 $1.06 Million
Q4 2021

Feb 04, 2022
BUY
$135.05 - $182.59 $609,075 - $823,480
4,510 Added 42.46%
15,131 $2.25 Million
Q3 2021

Oct 07, 2021
BUY
$145.58 - $192.14 $673,016 - $888,263
4,623 Added 77.08%
10,621 $1.55 Million
Q2 2021

Aug 04, 2021
BUY
$134.22 - $202.37 $282,667 - $426,191
2,106 Added 54.11%
5,998 $1.18 Million
Q1 2021

May 04, 2021
BUY
$140.25 - $196.86 $103,785 - $145,676
740 Added 23.48%
3,892 $704,000
Q4 2020

Feb 02, 2021
BUY
$126.47 - $163.7 $158,719 - $205,443
1,255 Added 66.16%
3,152 $446,000
Q3 2020

Oct 09, 2020
BUY
$87.44 - $125.0 $165,873 - $237,125
1,897 New
1,897 $237,000

Others Institutions Holding TXG

# of Institutions
335
Shares Held
116M
Call Options Held
442K
Put Options Held
149K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.18B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email